Biohit Oyj B (BIOBV) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Biohit Oyj B (BIOBV) has a cash flow conversion efficiency ratio of 0.040x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€600.00K ≈ $701.46K USD) by net assets (€14.90 Million ≈ $17.42 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Biohit Oyj B - Cash Flow Conversion Efficiency Trend (2000–2025)
This chart illustrates how Biohit Oyj B's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read Biohit Oyj B (BIOBV) financial obligations for a breakdown of total debt and financial obligations.
Biohit Oyj B Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Biohit Oyj B ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Laser Photonics Corporation Common Stock
NASDAQ:LASE
|
0.985x |
|
Botanix Pharmaceuticals Ltd
AU:BOT
|
-0.591x |
|
Acarix A/S
ST:ACARIX
|
-0.442x |
|
Radiopharm Theranostics Ltd
AU:RAD
|
-0.454x |
|
Kartal Yenilenebilir Enerji Uretim AS
IS:KARYE
|
-0.059x |
|
Farm Pride Foods Ltd
AU:FRM
|
0.183x |
|
Itama Ranoraya
JK:IRRA
|
-0.486x |
|
Fortune Indonesia Tbk
JK:FORU
|
-0.061x |
Annual Cash Flow Conversion Efficiency for Biohit Oyj B (2000–2025)
The table below shows the annual cash flow conversion efficiency of Biohit Oyj B from 2000 to 2025. For the full company profile with market capitalisation and key ratios, see BIOBV market cap overview.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | €14.90 Million ≈ $17.42 Million |
€-700.00K ≈ $-818.37K |
-0.047x | -197.81% |
| 2024-12-31 | €12.20 Million ≈ $14.26 Million |
€586.00K ≈ $685.10K |
0.048x | -49.81% |
| 2023-12-31 | €9.43 Million ≈ $11.02 Million |
€902.00K ≈ $1.05 Million |
0.096x | -61.38% |
| 2022-12-31 | €7.46 Million ≈ $8.72 Million |
€1.85 Million ≈ $2.16 Million |
0.248x | +507.40% |
| 2021-12-31 | €7.30 Million ≈ $8.53 Million |
€-444.00K ≈ $-519.08K |
-0.061x | -2017.33% |
| 2020-12-31 | €8.70 Million ≈ $10.17 Million |
€-25.00K ≈ $-29.23K |
-0.003x | -150.46% |
| 2019-12-31 | €14.58 Million ≈ $17.05 Million |
€83.00K ≈ $97.04K |
0.006x | +197.28% |
| 2018-12-31 | €15.89 Million ≈ $18.58 Million |
€-93.00K ≈ $-108.73K |
-0.006x | +89.30% |
| 2017-12-31 | €17.24 Million ≈ $20.16 Million |
€-943.00K ≈ $-1.10 Million |
-0.055x | +76.07% |
| 2016-12-31 | €10.75 Million ≈ $12.57 Million |
€-2.46 Million ≈ $-2.87 Million |
-0.229x | +25.12% |
| 2015-12-31 | €10.31 Million ≈ $12.05 Million |
€-3.15 Million ≈ $-3.68 Million |
-0.305x | -12.65% |
| 2014-12-31 | €12.68 Million ≈ $14.82 Million |
€-3.44 Million ≈ $-4.02 Million |
-0.271x | -36.91% |
| 2013-12-31 | €22.45 Million ≈ $26.25 Million |
€-4.44 Million ≈ $-5.19 Million |
-0.198x | +20.99% |
| 2012-12-31 | €35.49 Million ≈ $41.49 Million |
€-8.89 Million ≈ $-10.39 Million |
-0.250x | -367.03% |
| 2011-12-31 | €52.85 Million ≈ $61.78 Million |
€4.96 Million ≈ $5.80 Million |
0.094x | -37.80% |
| 2010-12-31 | €13.00 Million ≈ $15.20 Million |
€1.96 Million ≈ $2.29 Million |
0.151x | -31.23% |
| 2009-12-31 | €12.75 Million ≈ $14.90 Million |
€2.80 Million ≈ $3.27 Million |
0.219x | +130.61% |
| 2008-12-31 | €12.49 Million ≈ $14.60 Million |
€1.19 Million ≈ $1.39 Million |
0.095x | +8.29% |
| 2007-12-31 | €11.84 Million ≈ $13.84 Million |
€1.04 Million ≈ $1.22 Million |
0.088x | +1078.15% |
| 2006-12-31 | €13.41 Million ≈ $15.68 Million |
€100.00K ≈ $116.91K |
0.007x | -82.44% |
| 2005-12-31 | €14.25 Million ≈ $16.66 Million |
€605.00K ≈ $707.31K |
0.042x | -73.18% |
| 2004-12-31 | €14.14 Million ≈ $16.53 Million |
€2.24 Million ≈ $2.62 Million |
0.158x | +158.63% |
| 2003-12-31 | €14.10 Million ≈ $16.49 Million |
€863.00K ≈ $1.01 Million |
0.061x | -46.71% |
| 2001-12-31 | €16.33 Million ≈ $19.10 Million |
€1.88 Million ≈ $2.19 Million |
0.115x | +110.71% |
| 2000-12-31 | €98.02 Million ≈ $114.60 Million |
€5.34 Million ≈ $6.25 Million |
0.055x | -- |
About Biohit Oyj B
Biohit Oyj, a biotechnology company, manufactures and sells bind acetaldehyde, diagnostic products, and systems for diagnostic analysis for the use of research institutions, healthcare, and industry worldwide. The company's diagnostic tests product includes the GastroPanel Unified test panel for stomach health check; GastroPanel Four-in-One stomach test; GastroSoft software application to assist … Read more